Persistent Asset Partners’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,098	Closed	-$393K	–	157
2025 Q1	$393K	Sell	34,098 -7,854	-19%	-$90.6K	0.33%	66
2024 Q4	$374K	Buy	+41,952	New	+$374K	0.31%	72